Launch week offerEnds in00h00m00s

annual Promonthly Pro

Suping Zhang

Has grant

Professor

Shenzhen University

China

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Recent Grants

Grant: Open

Developing immunotherapeutic approaches to target gastrointestinal cancer

Open Date: 2024-01-01

Close Date: 2026-12-01

Grant: Close

Underlying mechanism of receptor tyrosine kinase orphan-receptor regulating Wnt signaling

Open Date: 2022-01-01

Close Date: 2025-12-01

Grant: Close

ROR2 in Breast Cancer Metastasis and Recurrence

Open Date: 2020-01-01

Close Date: 2023-12-01

Grant: Close

Targeted therapy of tyrosine kinase orphan receptor in malignant tumors

Open Date: 2019-04-01

Close Date: 2022-03-01

Grant: Close

A new target for breast cancer stem cells ROR2 research and antibody development

Open Date: 2018-04-01

Close Date: 2020-03-01

Articles (4)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (1)

Liang Ye

Associated Proferssor

Shenzhen University

CHINA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suping Zhang

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (4)

A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies

Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma

A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif

Immunotherapy shapes B-cell receptor repertoire to induce anti-tumor antibodies production in colon and lung cancer

Collaborators (1)

Liang Ye

Make your next move.